Completed PHASE3 INTERVENTIONAL 2-arm NCT02901379

Effect of 80-mg Atorvastatin on Myocardial Edema

Effect of 80-mg Atorvastatin on Myocardial Edema Following Coronary Artery Bypass Surgery in Relation With Follistatin-Like Protein-1

Sponsor: National Cardiovascular Center Harapan Kita Hospital Indonesia

Conditions Myocardial Edema

Interventions Atorvastatin 10mg Atorvastatin 80mg

Updated 7 times since 2017 Last updated: Aug 22, 2018 Started: Oct 31, 2016 Primary completion: Aug 31, 2018 Completion: Aug 31, 2018

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE3 clinical study on Myocardial Edema, this trial is completed. The trial is conducted by National Cardiovascular Center Harapan Kita Hospital Indonesia and has accumulated 7 data snapshots since 2016. Cardiovascular trials of this type often inform treatment guidelines for long-term patient management.

Status Flow

Change History

7 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE3
Jul 2024 — Sep 2024 [monthly]

Completed PHASE3
Jan 2021 — Jul 2024 [monthly]

Completed PHASE3
Sep 2018 — Jan 2021 [monthly]

Completed PHASE3

Status: Not Yet Recruiting → Completed
Jun 2018 — Sep 2018 [monthly]

Not Yet Recruiting PHASE3

▶ Show 2 earlier versions

Feb 2017 — Jun 2018 [monthly]

Not Yet Recruiting PHASE3
Jan 2017 — Feb 2017 [monthly]

Not Yet Recruiting PHASE3

First recorded

Oct 2016

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

National Cardiovascular Center Harapan Kita Hospital Indonesia

Data source: National Cardiovascular Center Harapan Kita Hospital Indonesia

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

No location information available.